Healthcare
France boosts infant bronchiolitis drug reimbursement
French health insurance will increase reimbursement rates for infant bronchiolitis drugs Beyfortus and Abrysvo to 65 percent starting at the end of August.
French health insurance will increase reimbursement rates for infant bronchiolitis drugs Beyfortus and Abrysvo to 65 percent starting at the end of August.